The Japanese conglomerate is in talks to spend up to $43 billion to boost the ChatGPT developer.

A new investment from the Japanese conglomerate would be separate from the $100 billion tied to a project announced at the ...

Helion secures funding to accelerate the development of its commercial-scale fusion power plant, aiming to deliver electricity to Microsoft.

(Reuters) - Helion, a startup working to generate electricity from nuclear fusion, on Tuesday said it has raised $425 million ...

SAN FRANCISCO - Developers at leading U.S. AI firms are praising the DeepSeek AI models that have leapt into prominence while ...

(Reuters) - OpenAI CEO Sam Altman called Chinese startup DeepSeek's R1 AI model "impressive" on Monday, but emphasized that ...

It’s an early step for OpenAI into the vaguely defined category of AI “ agents ,” which are intended to carry out multi-step ...

Three policy wonks dissect President Donald Trump’s executive orders on border security, immigration, government efficiency ...

Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT reports. © 2024 TechCrunch. All rights reserved. For personal use only.

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

What's trending in Bay Area business news this Friday morning: Twilio, EA Sports, Headlands Brewing, GameOn, 345 California, Retro Biosciences and more.